The global chromatography resin market size is estimated to reach USD 4.8 billion by 2033, expanding at a CAGR of 7.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growth is majorly driven by constantly increasing need for drug development activities for the production of biopharma and biological products for diagnostics.
Chromatography technique is used in therapeutic drug monitoring, which is used when a patient is on toxic medication to analyze the blood and urine levels. Tests such as blood, urine, stool, and umbilical cord on a regular basis are beneficial to ensure that the patient is taking an appropriate dose of medication. These technique helps companies develop and manufacture biological pharmaceutical tools to achieve safety and quality of active ingredients.
In North America, the pharmaceutical industry has been advancing for years and has grown at a faster rate, resulting in booming demand for ion exchange chromatography resin. Additionally, high healthcare spending and the presence of major pharmaceutical market leaders in the U.S. is the main driver of the chromatography resin market in the North America region.
Some of the key players operating in the industry are constantly undertaking initiatives to develop more effective and innovative products in an attempt to strengthen their position in the global market. In Covid-19 pandemic the chromatography resin manufacturers including Purolite, TriAltus Biosciences, and Avantor were majorly engaged in R&D activities for new product development. For instance, TriAltus Biosciences, a developer of innovative tools for protein purification developed novel CL7/Im7 system a protein purification technology. This technology was developed to aid the cancer institute for Covid-19 vaccine development.
Request a free sample copy or view report summary: Chromatography Resin Market Report
The Asia Pacific chromatography resin market is witnessing high economic growth across major regional countries such as China, India, and Japan among others is likely to boost the market growth.
In terms of technique, the ion exchange technique segment dominated the market with a revenue share of 43.7% in 2025.
Based on type, the natural segment dominated the market with a revenue share of 50.8% in 2025.
The pharmaceutical & biotechnology segment dominated the market with a revenue share of 83.0% in 2025.
North America region dominated the market with a revenue share of 33.0% in 2025. This high share is attributed to the growing demand for drug discovery to control diseases globally such as Ebola, Zika, and others.
The Asia Pacific chromatography resin market is witnessing high economic growth across major regional countries such as China, India, and Japan among others is likely to boost the market growth.
Grand View Research has segmented the global chromatography resin market based on product, technique, end use, and region:
Chromatography Resin Product Outlook (Volume, Thousand Liters; Revenue, USD Million, 2021 - 2033)
Natural
Synthetic
Other Products
Chromatography Resin Technique Outlook (Volume, Thousand Liters; Revenue, USD Million, 2021 - 2033)
Ion exchange
Affinity
Hydrophobic interaction
Size exclusion
Other Techniques
Chromatography Resin End Use Outlook (Volume, Thousand Liters; Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology
Food & Beverage
Other End Use
Chromatography Resin Regional Outlook (Volume, Thousand Liters; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Europe
Germany
France
UK
Asia Pacific
China
India
Japan
South Korea
Latin America
Brazil
Middle East & Africa
Saudi Arabia
List of Key Players in Chromatography Resin Market
Merck KGaA
Bio - Rad Laboratories, Inc.
WIPRO GE HEALTHCARE PVT LTD
Purolite Corporation
GRACE
Mitsubishi Chemical Holdings Corporation.
Danaher Corporation
Tosoh Corporation
Thermo Fisher Scientific Inc.
Sartorius AG
"The quality of research they have done for us has been excellent..."